Literature DB >> 27998724

Global Deletion of Glutathione S-Transferase A4 Exacerbates Developmental Nonalcoholic Steatohepatitis.

Martin Ronis1, Kelly Mercer2, Bridgette Engi3, Casey Pulliam4, Piotr Zimniak5, Leah Hennings6, Colin Shearn7, Thomas Badger8, Dennis Petersen7.   

Abstract

We established a mouse model of developmental nonalcoholic steatohepatitis (NASH) by feeding a high polyunsaturated fat liquid diet to female glutathione-S-transferase 4-4 (Gsta4-/-)/peroxisome proliferator activated receptor α (Ppara-/-) double knockout 129/SvJ mice for 12 weeks from weaning. We used it to probe the importance of lipid peroxidation in progression of NASH beyond simple steatosis. Feeding Gsta4-/-/Ppara-/- double-knockout (dKO) mice liquid diets containing corn oil resulted in a percentage fat-dependent increase in steatosis and necroinflammatory injury (P < 0.05). Increasing fat to 70% from 35% resulted in increases in formation of 4-hydroxynonenal protein adducts accompanied by evidence of stellate cell activation, matrix remodeling, and fibrosis (P < 0.05). Comparison of dKO mice with wild-type (Wt) and single knockout mice revealed additive effects of Gsta4-/- and Ppara-/- silencing on steatosis, 4-hydroxynonenal adduct formation, oxidative stress, serum alanine amino transferase, expression of tumor necrosis factor alpha, Il6, interferon mRNA, and liver pathology (P < 0.05). Induction of Cyp2e1 protein by high-fat diet was suppressed in Gsta4-/- and dKO groups (P < 0.05). The dKO mice had similar levels of markers of stellate cell activation and matrix remodeling as Ppara-/- single KO mice. These data suggest that lipid peroxidation products play a role in progression of liver injury to steatohepatitis in NASH produced by high-fat feeding during development but appear less important in development of fibrosis.
Copyright © 2017 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27998724      PMCID: PMC5389362          DOI: 10.1016/j.ajpath.2016.10.022

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  28 in total

1.  N-acetylcysteine attenuates progression of liver pathology in a rat model of nonalcoholic steatohepatitis.

Authors:  January N Baumgardner; Kartik Shankar; Leah Hennings; Emanuele Albano; Thomas M Badger; Martin J J Ronis
Journal:  J Nutr       Date:  2008-10       Impact factor: 4.798

2.  Mitochondrial alterations in nonalcoholic fatty liver disease. Pediatric case description of three submitted sequential biopsies.

Authors:  Gustavo Henrique Da Silva; Kunie Iabuki Rabello Coelho; Cláudio Antônio Rabello Coelho; Cecilia Amélia Fazzio Escanhoela
Journal:  J Gastrointestin Liver Dis       Date:  2009-06       Impact factor: 2.008

3.  The presence of p47phox in liver parenchymal cells is a key mediator in the pathogenesis of alcoholic liver steatosis.

Authors:  Ivan Levin; Jan Petrasek; Gyongyi Szabo
Journal:  Alcohol Clin Exp Res       Date:  2012-02-29       Impact factor: 3.455

Review 4.  Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease.

Authors:  Michal Pawlak; Philippe Lefebvre; Bart Staels
Journal:  J Hepatol       Date:  2014-11-01       Impact factor: 25.083

5.  Hepatocyte Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 4 Regulates Stress Signaling, Fibrosis, and Insulin Sensitivity During Development of Steatohepatitis in Mice.

Authors:  Ahmed Bettaieb; Joy X Jiang; Yu Sasaki; Tzu-I Chao; Zsofia Kiss; Xiangling Chen; Jijing Tian; Masato Katsuyama; Chihiro Yabe-Nishimura; Yannan Xi; Cedric Szyndralewiez; Kathrin Schröder; Ajay Shah; Ralph P Brandes; Fawaz G Haj; Natalie J Török
Journal:  Gastroenterology       Date:  2015-04-14       Impact factor: 22.682

6.  Increased 4-hydroxynonenal protein adducts in male GSTA4-4/PPAR-α double knockout mice enhance injury during early stages of alcoholic liver disease.

Authors:  Martin J J Ronis; Kelly E Mercer; Brenda Gannon; Bridgette Engi; Piotr Zimniak; Colin T Shearn; David J Orlicky; Emanuele Albano; Thomas M Badger; Dennis R Petersen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-11       Impact factor: 4.052

7.  Physiological role of mGSTA4-4, a glutathione S-transferase metabolizing 4-hydroxynonenal: generation and analysis of mGsta4 null mouse.

Authors:  Mark R Engle; Sharda P Singh; Piotr J Czernik; Dana Gaddy; Donna C Montague; Jeffrey D Ceci; Yusong Yang; Sanjay Awasthi; Yogesh C Awasthi; Piotr Zimniak
Journal:  Toxicol Appl Pharmacol       Date:  2004-02-01       Impact factor: 4.219

8.  Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production.

Authors:  Meihui Pan; Arthur I Cederbaum; Yuan-Li Zhang; Henry N Ginsberg; Kevin Jon Williams; Edward A Fisher
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

Review 9.  Nonalcoholic Fatty liver disease/non-alcoholic steatohepatitis in childhood: endocrine-metabolic "mal-programming".

Authors:  Sara Manti; Claudio Romano; Valeria Chirico; Martina Filippelli; Caterina Cuppari; Italia Loddo; Carmelo Salpietro; Teresa Arrigo
Journal:  Hepat Mon       Date:  2014-05-01       Impact factor: 0.660

Review 10.  Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets.

Authors:  Valentina Giorgio; Federica Prono; Francesca Graziano; Valerio Nobili
Journal:  BMC Pediatr       Date:  2013-03-25       Impact factor: 2.125

View more
  5 in total

1.  Knockout of the Gsta4 Gene in Male Mice Leads to an Altered Pattern of Hepatic Protein Carbonylation and Enhanced Inflammation Following Chronic Consumption of an Ethanol Diet.

Authors:  Colin T Shearn; Casey F Pulliam; Kim Pedersen; Kyle Meredith; Kelly E Mercer; Laura M Saba; David J Orlicky; Martin J Ronis; Dennis R Petersen
Journal:  Alcohol Clin Exp Res       Date:  2018-05-30       Impact factor: 3.455

2.  Application of an In Vivo Hepatic Triacylglycerol Production Method in the Setting of a High-Fat Diet in Mice.

Authors:  Kikumi D Ono-Moore; Matthew Ferguson; Michael L Blackburn; Hassan Issafras; Sean H Adams
Journal:  Nutrients       Date:  2016-12-28       Impact factor: 5.717

3.  Potential role of gut microbiota, the proto-oncogene PIKE (Agap2) and cytochrome P450 CYP2W1 in promotion of liver cancer by alcoholic and nonalcoholic fatty liver disease and protection by dietary soy protein.

Authors:  Martin J Ronis; Kelly E Mercer; Kartik Shankar; Casey Pulliam; Kim Pedersen; Magnus Ingelman-Sundberg; Simonetta Friso; Derrick Samuelson; Luis Del Valle; Chris Taylor; David A Welsh
Journal:  Chem Biol Interact       Date:  2020-05-14       Impact factor: 5.192

4.  Role of Nutrition in Alcoholic Liver Disease: Summary of the Symposium at the ESBRA 2017 Congress.

Authors:  Kusum K Kharbanda; Martin J J Ronis; Colin T Shearn; Dennis R Petersen; Samir Zakhari; Dennis R Warner; Ariel E Feldstein; Craig J McClain; Irina A Kirpich
Journal:  Biomolecules       Date:  2018-03-26

5.  Phenotypic Variability in Phelan-McDermid Syndrome and Its Putative Link to Environmental Factors.

Authors:  Luigi Boccuto; Andrew Mitz; Ludovico Abenavoli; Sara M Sarasua; William Bennett; Curtis Rogers; Barbara DuPont; Katy Phelan
Journal:  Genes (Basel)       Date:  2022-03-17       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.